UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of Levodopa in Lung Functions in Patients with Parkinson′s Disease

Annals of the Indian Academy of Neurology, 2021-11, Vol.24 (6), p.935-936

Al-Mendalawi, Mahmood

2021

Volltextzugriff (PDF)

Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients

Movement disorders, 2016-04, Vol.31 (4), p.530-537

2016

Volltextzugriff (PDF)

Levodopa challenge test: indications, protocol, and guide

Journal of neurology, 2021-09, Vol.268 (9), p.3135-3143

2021

Volltextzugriff (PDF)

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

Movement disorders, 2010-11, Vol.25 (15), p.2649-2653

2010

Volltextzugriff (PDF)

Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease

Clinical therapeutics, 2020-06, Vol.42 (6), p.1034-1046

2020

Volltextzugriff (PDF)

An electrochemical biosensor based on nanoporous stainless steel modified by gold and palladium nanoparticles for simultaneous determination of levodopa and uric acid

Talanta (Oxford), 2016-09, Vol.158, p.42-50

2016

Volltextzugriff (PDF)

Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study

Movement disorders, 2019-03, Vol.34 (3), p.425-429

2019

Volltextzugriff (PDF)

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease

Nature communications, 2019-01, Vol.10 (1), p.310-310, Article 310

2019

Volltextzugriff (PDF)

The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson’s disease

Journal of neurology, 2024-07, Vol.271 (7), p.3711-3720

2024

Volltextzugriff (PDF)

A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease

Movement disorders, 2016-09, Vol.31 (9), p.1356-1365

2016

Volltextzugriff (PDF)

In Matrix Derivatization Combined with LC-MS/MS Results in Ultrasensitive Quantification of Plasma Free Metanephrines and Catecholamines

Analytical chemistry (Washington), 2020-07, Vol.92 (13), p.9072-9078

2020

Volltextzugriff (PDF)

Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease

The New England journal of medicine, 2019-01, Vol.380 (4), p.315-324

2019

Volltextzugriff (PDF)

Erratum: Figge et al., “Differential Activation States of Direct Pathway Striatal Output Neurons during l-DOPA-Induced Dyskinesia Development”

The Journal of neuroscience, 2024-09, p.e1445242024

2024

Volltextzugriff (PDF)

Levodopa‐Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial

Movement disorders, 2021-11, Vol.36 (11), p.2615-2623

2021

Volltextzugriff (PDF)

Disruption of mitochondrial complex I induces progressive parkinsonism

Nature (London), 2021-11, Vol.599 (7886), p.650-656

2021

Volltextzugriff (PDF)

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Lancet neurology, 2014-02, Vol.13 (2), p.141-149

2014

Volltextzugriff (PDF)

Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson’s disease: a systematic review and meta-analysis

Journal of neurology, 2022-02, Vol.269 (2), p.703-711

2022

Volltextzugriff (PDF)

Simultaneous sensing of carbidopa and levodopa by a novel strategy based on dual‐emission ratiometric assay of modified carbon dots

Biotechnology and applied biochemistry, 2024-10, Vol.71 (5), p.1032-1043

2024

Volltextzugriff (PDF)

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

The AAPS journal, 2013-04, Vol.15 (2), p.316-323

2013

Volltextzugriff (PDF)

Wearable Sweat Band for Noninvasive Levodopa Monitoring

Nano letters, 2019-09, Vol.19 (9), p.6346-6351

2019

Volltextzugriff (PDF)

Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease

Movement disorders, 2015-09, Vol.30 (10), p.1361-1370

2015

Volltextzugriff (PDF)

Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

Movement disorders, 2015-01, Vol.30 (1), p.64-72

LeWitt, Peter A.

2015

Volltextzugriff (PDF)

Levodopa: Past, Present, and Future

European neurology, 2009-01, Vol.62 (1), p.1-8

Hauser, Robert A.

2009

Volltextzugriff (PDF)

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

Movement disorders, 2015-05, Vol.30 (6), p.788-795

2015

Volltextzugriff (PDF)

1 – 25 von 20.975

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18.694)
Mit Volltextzugriff
(14.811)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(18.849)
Russisch
(378)
Japanisch
(360)
Französisch
(342)
Deutsch
(321)
Spanisch
(285)
Italienisch
(158)
Polnisch
(86)
Chinesisch
(82)
Portugiesisch
(38)
Niederländisch
(26)
Ungarisch
(26)
Norwegisch
(15)
Serbian
(13)
Schwedisch
(13)
Finnisch
(12)
Dänisch
(11)
Tschechisch
(10)
Hebräisch
(10)
Koreanisch
(8)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(15.682)
Life Sciences & Biomedicine
(14.745)
Humans
(12.925)
Male
(9.677)
Neurosciences & Neurology
(9.384)
Levodopa - Therapeutic Use
(7.527)
Female
(7.487)
Parkinson Disease - Drug Therapy
(7.457)
Parkinson's Disease
(6.727)
Levodopa
(6.580)
Clinical Neurology
(6.208)
Animals
(5.898)
Middle Aged
(5.645)
Neurosciences
(5.197)
Aged
(5.069)
Biological And Medical Sciences
(4.846)
Medical Sciences
(4.318)
Levodopa - Pharmacology
(4.219)
Neurology
(3.618)
Levodopa - Adverse Effects
(3.549)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(18.062)
Ingenta
(9.787)
Journals@Ovid Full Text
(8.696)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(6.084)
ScienceDirect Journals (5 years ago - present)
(4.373)
Wiley-Blackwell Journals
(3.415)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(3.193)
Publisher or Other Site
(3.099)
IngentaConnect Journals
(3.022)
Wiley Online Library Full Collection 2018
(2.954)
Springer journals
(2.334)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.531)
Psychology & Behavioral Sciences Collection
(758)
Oxford journals
(578)
Taylor & Francis Journals
(576)
Taylor & Francis
(509)
BMJ Publishing
(437)
Taylor & Francis:Master (3349 titles)
(433)
Oxford Journals 2020 Medicine
(421)
BMJ Journals Archiv - DFG Nationallizenzen
(333)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Movement Disorders
(1.142)
Neurology
(680)
Parkinsonism & Related Disorders
(458)
Clinical Neuropharmacology
(381)
Journal Of Neural Transmission
(335)
Journal Of Neurology, Neurosurgery And Psychiatry
(282)
Advances In Neurology
(269)
Journal Of Neurology
(240)
Annals Of Neurology
(231)
Brain Research
(217)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Impact of Levodopa in Lung Functions in Patients with Parkinson′s Disease

Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients

Levodopa challenge test: indications, protocol, and guide

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease

An electrochemical biosensor based on nanoporous stainless steel modified by gold and palladium nanoparticles for simultaneous determination of levodopa and uric acid

Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease

The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson’s disease

A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease

In Matrix Derivatization Combined with LC-MS/MS Results in Ultrasensitive Quantification of Plasma Free Metanephrines and Catecholamines

Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease

Erratum: Figge et al., “Differential Activation States of Direct Pathway Striatal Output Neurons during l-DOPA-Induced Dyskinesia Development”

Levodopa‐Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial

Disruption of mitochondrial complex I induces progressive parkinsonism

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson’s disease: a systematic review and meta-analysis

Simultaneous sensing of carbidopa and levodopa by a novel strategy based on dual‐emission ratiometric assay of modified carbon dots

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

Wearable Sweat Band for Noninvasive Levodopa Monitoring

Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease

Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

Levodopa: Past, Present, and Future

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

Suchergebnisse filtern